期刊文献+

芹菜素干预非酒精性脂肪肝的研究进展

Research Progress of Apigenin in the Intervention of Non-alcoholic Fatty Liver
下载PDF
导出
摘要 目前,非酒精性脂肪肝病作为一个热门医学话题,其发病率正呈逐年增高的态势,且越来越趋于年轻化,现已得到人们的广泛关注。芹菜素(API)是一种天然黄酮类化合物,含有多种药理活性。大量文献也充分说明芹菜素对非酒精性脂肪肝疾病起到积极预防和治疗的作用,主要是通过干扰炎性介质释放、改善胰岛素敏感性、调节脂质代谢相关基因表达以及抗氧化作用等。 At present, non-alcoholic fatty liver disease is a hot medical topic, and its incidence is increasing year by year, and it is getting younger and younger, which has been widely concerned by people. Apigenin(API) is a kind of natural flavonoids with many pharmacological activities. A large number of literatures also fully show that apigenin plays an active role in the prevention and treatment of non-alcoholic fatty liver diseases. mainly by interfering with the release of inflammatory mediators, improving insulin sensitivity, regulating the expression of genes related to lipid metabolism and antioxidation.
作者 付海洋 周奎臣 Fu Haiyang;Zhou Kuichen(Jiamusi University,Jiamusi 154007;Department of Laboratory,the First Affiliated Hospital of Jiamusi University,Jiamusi 154003,China)
出处 《广东化工》 CAS 2020年第14期88-89,96,共3页 Guangdong Chemical Industry
基金 国家自然科学青年基金(21302223)。
关键词 非酒精性脂肪肝 芹菜素 氧化应激 脂质代谢 nonalcoholic fatty liver apigenin oxidative stress lipid metabolism
  • 相关文献

参考文献11

二级参考文献60

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部